Zacks: Brokerages Anticipate Walgreens Boots Alliance Inc (WBA) Will Announce Quarterly Sales of $31.99 Billion

Wall Street analysts expect Walgreens Boots Alliance Inc (NASDAQ:WBA) to post sales of $31.99 billion for the current quarter, according to Zacks Investment Research. Nine analysts have made estimates for Walgreens Boots Alliance’s earnings. The lowest sales estimate is $30.92 billion and the highest is $33.02 billion. Walgreens Boots Alliance reported sales of $29.45 billion in the same quarter last year, which would suggest a positive year over year growth rate of 8.6%. The company is scheduled to issue its next quarterly earnings report on Wednesday, April 4th.

On average, analysts expect that Walgreens Boots Alliance will report full year sales of $31.99 billion for the current year, with estimates ranging from $123.89 billion to $132.88 billion. For the next financial year, analysts anticipate that the business will report sales of $136.67 billion per share, with estimates ranging from $127.83 billion to $143.68 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Walgreens Boots Alliance.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the company posted $1.10 EPS.

A number of equities analysts recently commented on the stock. Needham & Company LLC decreased their target price on shares of Walgreens Boots Alliance to $86.00 and set a “buy” rating on the stock in a research report on Wednesday, November 22nd. Jefferies Group set a $93.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Sunday, October 29th. Pivotal Research set a $73.00 target price on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Friday, January 5th. Vetr upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. Finally, Zacks Investment Research cut shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Monday, January 22nd. Eleven analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $85.53.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at $71.79 on Wednesday. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. The firm has a market cap of $71,120.00, a price-to-earnings ratio of 19.83, a PEG ratio of 1.24 and a beta of 1.18. Walgreens Boots Alliance has a 52-week low of $63.82 and a 52-week high of $88.00.

The company also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 44.20%.

Walgreens Boots Alliance announced that its Board of Directors has initiated a share repurchase program on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.

In other news, insider Stefano Pessina purchased 98,858 shares of the business’s stock in a transaction on Monday, January 15th. The shares were acquired at an average price of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 14.80% of the stock is owned by company insiders.

A number of institutional investors have recently made changes to their positions in the business. Hudock Capital Group LLC boosted its stake in shares of Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares in the last quarter. Westside Investment Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 10.4% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares in the last quarter. Zions Bancorporation boosted its stake in shares of Walgreens Boots Alliance by 983.3% during the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 1,239 shares in the last quarter. IHT Wealth Management LLC boosted its stake in shares of Walgreens Boots Alliance by 46.3% during the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 2,199 shares in the last quarter. Finally, Bristlecone Advisors LLC bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at about $135,000. 61.24% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Zacks: Brokerages Anticipate Walgreens Boots Alliance Inc (WBA) Will Announce Quarterly Sales of $31.99 Billion” was originally published by American Banking News and is the property of of American Banking News. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/07/zacks-brokerages-anticipate-walgreens-boots-alliance-inc-wba-will-announce-quarterly-sales-of-31-99-billion.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply